ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 807

$696K Total Retail Price of All Prescriptions

Rank: 38 out of 807

641 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 641 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 641 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 11,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 697 666 1 1
OMEPRAZOLE 413 402 2 4
ATENOLOL 362 344 3 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 353 343 4 28
AMLODIPINE BESYLATE 351 351 5 5
WARFARIN SODIUM 331 301 6 10
LISINOPRIL 330 307 7 2
LEVOTHYROXINE SODIUM 318 303 8 3
CITALOPRAM HBR 308 291 9 17
HYDROCODONE-ACETAMINOPHEN 307 274 S3 10 15
FUROSEMIDE 299 296 11 6
ATORVASTATIN CALCIUM 295 279 12 11
POTASSIUM CHLORIDE 229 213 13 18
METOPROLOL SUCCINATE 197 183 14 13
METOPROLOL TARTRATE 184 181 15 8
HYDROCHLOROTHIAZIDE 178 174 16 9
PREDNISONE 150 148 17 24
LOSARTAN-HYDROCHLOROTHIAZIDE 144 132 18 55
CRESTOR 141 123 19 32
TRAZODONE HCL 134 129 20 25
AMLODIPINE BESYLATE-BENAZEPRIL 129 107 21 117
METFORMIN HCL 123 106 22 12
ALLOPURINOL 116 113 23 26
TRAMADOL HCL 107 83 24 19
GABAPENTIN 103 73 25 16
SPIRONOLACTONE 102 100 26 48
CLOPIDOGREL 100 100 27 47
LANTUS 96 83 28 45
FENTANYL 96 96 S2 28 65
CARVEDILOL 88 87 30 35
ADVAIR DISKUS 88 71 30 33
LOSARTAN POTASSIUM 87 87 32 14
TAMSULOSIN HCL 86 81 33 27
ZOLPIDEM TARTRATE 84 77 34 23
GLIPIZIDE ER 82 82 35 67
METFORMIN HCL ER 81 64 36 61
QUETIAPINE FUMARATE 79 79 37 66
JANUVIA 78 65 38 79
CELEBREX 76 75 39 87
GLYBURIDE-METFORMIN HCL 75 75 R 40 235
RANITIDINE HCL 75 68 40 34
PANTOPRAZOLE SODIUM 74 63 42 44
ATENOLOL-CHLORTHALIDONE 73 70 43 132
PRAVASTATIN SODIUM 69 69 44 21
DIGOXIN 67 66 45 41
PLAVIX 66 66 46 60
AMITRIPTYLINE HCL 66 65 R 46 71
NAMENDA 66 66 46 54
POLYETHYLENE GLYCOL 3350 63 52 49 40
CYMBALTA 60 47 50 73
AZITHROMYCIN 60 53 50 57
FLUTICASONE PROPIONATE 58 46 52 30
LOVASTATIN 57 57 53 39
SPIRONOLACTONE-HCTZ 56 44 54 180
SERTRALINE HCL 53 52 55 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.